Echo Street Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Echo Street Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $375,844 - $434,900	4,336 Added 190.51%	6,612 $573,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $199,696 - $266,906	2,276 New	2,276 $221,000
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $799,334 - $943,129	9,729 New	9,729 $825,000
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $1.04 Million - $1.27 Million	-14,612 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $1.09 Million - $1.35 Million	14,612 New	14,612 $1.13 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $374,522 - $428,119	-5,009 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $130,632 - $146,686	1,730 Added 52.76%	5,009 $418,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $245,039 - $297,372	3,279 New	3,279 $248,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.